Commentary on a study on whether the timing from surgery to adjuvant chemotherapy affects survival in patients with colorectal cancer, published June 2011 in JAMA. br / iMedscape General Surgery/i
Data pooled from 4 large randomized trials show that patients with metastatic colorectal cancer are not likely to benefit from EGFR inhibitors if their tumors have mutations in the KRAS gene Medscape Medical News
Factor V level on day 3 of hospitalization was strongly associated with survival in HBV-associated acute liver failure, with levels of 0% to 10% among those who died and 7% to 25% for survivors. Medscape Medical News
Anemia that develops in patients infected with hepatitis C virus (HCV) during treatment with peginterferon-alfa and ribavirin (PEG-IFN/RBV) may be a good sign, new research hints. Reuters Health Information
Is past hepatitis B virus infection a significant risk factor for hepatocellular carcinoma among patients with hepatitis C virus? Journal of Viral Hepatitis
Nonsteroidal anti-inflammatory drugs (NSAIDs) have shown promise in the chemopreventive of colorectal cancer, but new data suggest that they might also reduce disease-specific mortality. Medscape Medical News